In 2023, Bayer Consumer Health expanded the remit of its 4-year-old in-house agency (known internally as “ContentHaus”) to include decoupled production – effectively centralizing all third-party production management, from asset planning to pre-pro to post. This session will explain the business case for bringing production in-house, the process of building world-class production capability within the business, how Bayer and OLIVER work with Bayer’s roster of external AORs, and the scale, quality, and savings achieved.